Kiaan Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 12-12-2024
- Paid Up Capital ₹ 2.20 M
as on 12-12-2024
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
as on 12-12-2024
- Satisfied Charges ₹ 6.50 M
as on 12-12-2024
- Revenue -62.64%
(FY 2022)
- Profit 5.43%
(FY 2022)
- Ebitda -200.00%
(FY 2022)
- Net Worth 2.95%
(FY 2022)
- Total Assets 12.35%
(FY 2022)
About Kiaan Pharma
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.20 M.
The company currently has active open charges totaling ₹4.00 M. The company has closed loans amounting to ₹6.50 M, as per Ministry of Corporate Affairs (MCA) records.
Vaishali Rajvanshi and Ganga Singh serve as directors at the Company.
- CIN/LLPIN
U24233UP2012PTC051891
- Company No.
051891
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Aug 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Muzaffarnagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kiaan Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vaishali Rajvanshi  | Additional Director | 23-Oct-2024 | Current |
| Ganga Singh | Director | 05-Feb-2024 | Current |
Financial Performance of Kiaan Pharma.
Kiaan Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 62.64% decrease. The company also saw a slight improvement in profitability, with a 5.43% increase in profit. The company's net worth moved up by a moderate rise of 2.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kiaan Pharma?
In 2019, Kiaan Pharma had a promoter holding of 30.00% and a public holding of 70.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 May 2023 | ₹4.00 M | Open |
Punjab National Bank Creation Date: 23 May 2013 | ₹6.50 M | Satisfied |
How Many Employees Work at Kiaan Pharma?
Unlock and access historical data on people associated with Kiaan Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kiaan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kiaan Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
